GR-1®/RC-14® and Vaginal FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lacticaseibacillus rhamnosus GR-1®‡ and Limosilactobacillus reuteri RC-14®‡, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.
‡Updates based on official taxonomy reclassification.
**25+ Years of GR-1®/RC-14® research/clinical studies.
For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
Dextrose anhydrate, potato starch, cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Milk (in trace amounts).
No wheat, gluten, soybeans, egg, fish/shellfish, or peanuts/tree nuts.
Keep refrigerated.
Keep out of the reach of children.
Consult a healthcare professional before using this product if you are trying to conceive, pregnant, or lactating, under the age of 18, or have a medical condition- if adverse reactions occur, discontinue use.
| Поживна цінність | ||
| Serving Size: 1 Capsule | ||
| Amount Per Serving: | % DV | |
| Proprietary Probiotic Blend Lacticaseibacillus rhamnosus, GR-1®† Limosilactobacillus reuteri, RC-14® † | 134 mg (5 Billion CFU§) | †† †† †† |
| ††Daily Value (DV) not established. † Under License from Chr. Hansen A/S and protected by Chr. Hansen patents of the WO 00/35465 patented family, and others. §Minimum 5 billion viable cells at time of consumption, under recommended storage conditions and within Best Used Before date. | ||